<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7306998\results\search\disease\results.xml">
  <result pre="Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). Abstract An ongoing global pandemic of" exact="viral pneumonia" post="(coronavirus disease [COVID-19]), due to the virus SARS-CoV-2, has"/>
  <result pre="Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). Abstract An ongoing global pandemic of viral" exact="pneumonia" post="(coronavirus disease [COVID-19]), due to the virus SARS-CoV-2, has"/>
  <result pre="(https://us.sagepub.com/en-us/nam/open-access-at-sage). Abstract An ongoing global pandemic of viral pneumonia (coronavirus" exact="disease" post="[COVID-19]), due to the virus SARS-CoV-2, has infected millions"/>
  <result pre="a threat to many more. Most critically ill patients have" exact="respiratory" post="failure and there is an international effort to understand"/>
  <result pre="is an international effort to understand mechanisms and predictors of" exact="disease" post="severity. Coagulopathy, characterized by elevations in D-dimer and fibrin(ogen)"/>
  <result pre="with COVID-19-associated coagulopathy, and prior studies of hemostasis in other" exact="viral" post="infections and acute respiratory distress syndrome. We hypothesize that"/>
  <result pre="COVID-19-associated coagulopathy, and prior studies of hemostasis in other viral" exact="infections" post="and acute respiratory distress syndrome. We hypothesize that an"/>
  <result pre="and prior studies of hemostasis in other viral infections and" exact="acute" post="respiratory distress syndrome. We hypothesize that an imbalance between"/>
  <result pre="prior studies of hemostasis in other viral infections and acute" exact="respiratory" post="distress syndrome. We hypothesize that an imbalance between coagulation"/>
  <result pre="coagulation and inflammation may result in a hypercoagulable state. Although" exact="thrombosis" post="initiated by the innate immune system is hypothesized to"/>
  <result pre="in COVID-19. anticoagulation antiplatelet coagulation coronavirus COVID-19 inflammation NETs neutrophils" exact="thrombosis" post="vascular endothelium venous thromboembolism (VTE) Funding National Heart, Lung,"/>
  <result pre="COVID-19. anticoagulation antiplatelet coagulation coronavirus COVID-19 inflammation NETs neutrophils thrombosis" exact="vascular" post="endothelium venous thromboembolism (VTE) Funding National Heart, Lung, and"/>
  <result pre="antiplatelet coagulation coronavirus COVID-19 inflammation NETs neutrophils thrombosis vascular endothelium" exact="venous thromboembolism" post="(VTE) Funding National Heart, Lung, and Blood Institutehttps://doi.org/10.13039/100000050 K08HL131993"/>
  <result pre="vascular endothelium venous thromboembolism (VTE) Funding National Heart, Lung, and" exact="Blood" post="Institutehttps://doi.org/10.13039/100000050 K08HL131993 National Heart, Lung, and Blood Institutehttps://doi.org/10.13039/100000050 R01HL150392"/>
  <result pre="Heart, Lung, and Blood Institutehttps://doi.org/10.13039/100000050 K08HL131993 National Heart, Lung, and" exact="Blood" post="Institutehttps://doi.org/10.13039/100000050 R01HL150392 Dr. Ralph and Marian Falk Medical Research"/>
  <result pre="Dr. Ralph and Marian Falk Medical Research Trusthttps://doi.org/10.13039/100008590 Catalyst Award" exact="American" post="Venous Forumhttps://doi.org/10.13039/100013442 JOBST-AVFF award Frankel Cardiovascular Center COVID-19 Cardiovascular"/>
  <result pre="Institute Award Introduction In December 2019, a new betacoronavirus (severe" exact="acute" post="respiratory syndrome coronavirus 2 [SARS-CoV-2]), thought to originate in"/>
  <result pre="Award Introduction In December 2019, a new betacoronavirus (severe acute" exact="respiratory" post="syndrome coronavirus 2 [SARS-CoV-2]), thought to originate in Wuhan,"/>
  <result pre="Introduction In December 2019, a new betacoronavirus (severe acute respiratory" exact="syndrome" post="coronavirus 2 [SARS-CoV-2]), thought to originate in Wuhan, China,"/>
  <result pre="in Wuhan, China, emerged as a novel human pathogen for" exact="viral pneumonia" post="(coronavirus disease [COVID-19]), resulting in an ongoing pandemic.1,2 The"/>
  <result pre="Wuhan, China, emerged as a novel human pathogen for viral" exact="pneumonia" post="(coronavirus disease [COVID-19]), resulting in an ongoing pandemic.1,2 The"/>
  <result pre="emerged as a novel human pathogen for viral pneumonia (coronavirus" exact="disease" post="[COVID-19]), resulting in an ongoing pandemic.1,2 The number of"/>
  <result pre="deaths, triggering a global effort to understand the predictors of" exact="disease" post="severity for rapid triage, and the pathology of disease"/>
  <result pre="of disease severity for rapid triage, and the pathology of" exact="disease" post="for rational therapeutic development and clinical trials. A consistent"/>
  <result pre="mortality.3â€&quot;7 We aim to review the available data on the" exact="coagulopathy" post="observed in COVID-19 and draw from studies of prior"/>
  <result pre="coagulopathy observed in COVID-19 and draw from studies of prior" exact="viral" post="epidemics to explore possible mechanisms and therapies. Coronaviruses are"/>
  <result pre="the Nidovirales order within the Coronaviridae family. Different strains are" exact="infectious" post="to a broad range of animals including humans, bats,"/>
  <result pre="cats, racoon dogs, rabbits, pigs, and cattle.8 In general, coronavirus" exact="infections" post="in humans are mild; however, two recent epidemics of"/>
  <result pre="epidemics of betacoronaviruses â€&quot; SARS in 20039â€&quot;11 and Middle East" exact="Respiratory" post="Syndrome (MERS) in 201212,13 â€&quot; were associated with significant"/>
  <result pre="of betacoronaviruses â€&quot; SARS in 20039â€&quot;11 and Middle East Respiratory" exact="Syndrome" post="(MERS) in 201212,13 â€&quot; were associated with significant mortality"/>
  <result pre="is much higher due to the global spread of the" exact="disease" post="and the infectivity of the virus,18 and worldwide fatalities"/>
  <result pre="rate of 2â€&quot;2.5%. All deaths occurred in patients with critical" exact="disease" post="(in which the case fatality rate was almost 50%).19"/>
  <result pre="the majority of critically ill patients with COVID-19 have isolated" exact="respiratory" post="failure, often acute respiratory distress syndrome (ARDS), multiple organ"/>
  <result pre="critically ill patients with COVID-19 have isolated respiratory failure, often" exact="acute" post="respiratory distress syndrome (ARDS), multiple organ dysfunction occurs in"/>
  <result pre="ill patients with COVID-19 have isolated respiratory failure, often acute" exact="respiratory" post="distress syndrome (ARDS), multiple organ dysfunction occurs in 20â€&quot;30%"/>
  <result pre="with COVID-19 have isolated respiratory failure, often acute respiratory distress" exact="syndrome" post="(ARDS), multiple organ dysfunction occurs in 20â€&quot;30% of patients"/>
  <result pre="in fatal cases.16 Hematologic findings, such as mild to moderate" exact="thrombocytopenia" post="and lymphopenia, are associated with COVID-19;20,21 however, the most"/>
  <result pre="are associated with COVID-19;20,21 however, the most significant and concerning" exact="vascular" post="aspect of this disease is coagulopathy. We have attempted"/>
  <result pre="however, the most significant and concerning vascular aspect of this" exact="disease" post="is coagulopathy. We have attempted to summarize the data"/>
  <result pre="the pathogenesis, epidemiology and outcomes related to COVID-19-coagulopathy and thrombotic" exact="disease" post="using PubMed as well as the pre-print server https://medrxiv.org"/>
  <result pre="last search April 23, 2020). Coagulopathy of SARS-CoV-2 and other" exact="infections" post="There is particular interest in the coagulopathy in patients"/>
  <result pre="SARS-CoV-2 and other infections There is particular interest in the" exact="coagulopathy" post="in patients with COVID-19 as abnormal coagulation parameters, most"/>
  <result pre="most consistently elevations in D-dimer and FDPs, are associated with" exact="disease" post="severity.22,23 An elevated D-dimer, the most common coagulation abnormality"/>
  <result pre="are almost 20 times more likely to die from their" exact="infection" post="than patients with lower D-dimer values.25 In contrast, most"/>
  <result pre="more likely to die from their infection than patients with" exact="lower" post="D-dimer values.25 In contrast, most patients with COVID-19 have"/>
  <result pre="prolonged prothrombin time (PT) and a normal or shortened activated" exact="partial" post="thromboplastin time (aPTT) on presentation and these labs are"/>
  <result pre="on presentation and these labs are not reliably associated with" exact="disease" post="severity.5,17,22,24,25 Both initial and longitudinal monitoring of coagulation parameters"/>
  <result pre="Both initial and longitudinal monitoring of coagulation parameters can predict" exact="disease" post="severity, as elevated D-dimer and FDP levels on admission"/>
  <result pre="would not be unexpected. These findings may be due to" exact="uncontrolled" post="activation of coagulation with ongoing consumption and widespread microvascular"/>
  <result pre="may be due to uncontrolled activation of coagulation with ongoing" exact="consumption" post="and widespread microvascular thrombosis. While early descriptions of the"/>
  <result pre="consumption and widespread microvascular thrombosis. While early descriptions of the" exact="coagulopathy" post="identified it as disseminated intravascular coagulation (DIC), in DIC,"/>
  <result pre="thrombosis. While early descriptions of the coagulopathy identified it as" exact="disseminated intravascular coagulation" post="(DIC), in DIC, unlike in severe COVID-19, platelet count"/>
  <result pre="their admission, elevations in D-dimer and prolonged PT with mild" exact="thrombocytopenia" post="and normal fibrinogen are commonly seen.23 Thromboelastography in patients"/>
  <result pre="of critically ill patients with COVID-19 is distinct from traditional" exact="systemic" post="DIC and may be due to a unique coagulopathy."/>
  <result pre="D-dimer are common in critical illness and are associated with" exact="disease" post="severity and mortality in many severe infections.29â€&quot;31 Patients with"/>
  <result pre="in SARS.33â€&quot;35 Additionally, in the H1N1 pandemic, patients with severe" exact="disease" post="had high rates of venous thromboembolism (VTE) and many"/>
  <result pre="H1N1 pandemic, patients with severe disease had high rates of" exact="venous thromboembolism" post="(VTE) and many patients with thromboembolism did not have"/>
  <result pre="and many patients with thromboembolism did not have evidence of" exact="systemic" post="DIC.36â€&quot;39 Patients with ARDS from H1N1 infection had a"/>
  <result pre="have evidence of systemic DIC.36â€&quot;39 Patients with ARDS from H1N1" exact="infection" post="had a greater than 20-fold increase in risk of"/>
  <result pre="infection had a greater than 20-fold increase in risk of" exact="pulmonary embolism" post="compared to patients with ARDS unrelated to H1N1.39 Empiric"/>
  <result pre="in patients hospitalized with COVID-19 and is associated with severe" exact="disease" post="and high risk of mortality.44,45 Myocardial injury may result"/>
  <result pre="and high risk of mortality.44,45 Myocardial injury may result from" exact="systemic" post="inflammatory response syndrome (SIRS) and inflammation as well as"/>
  <result pre="of mortality.44,45 Myocardial injury may result from systemic inflammatory response" exact="syndrome" post="(SIRS) and inflammation as well as due to acute"/>
  <result pre="response syndrome (SIRS) and inflammation as well as due to" exact="acute" post="thrombotic events.46,47 Similar observations of myocardial injury have been"/>
  <result pre="of myocardial injury have been found in patients with other" exact="viral" post="infections.48,49 Pathologic findings in SARS-CoV-2 infection Although there are"/>
  <result pre="in patients with other viral infections.48,49 Pathologic findings in SARS-CoV-2" exact="infection" post="Although there are only a few published pathologic reports"/>
  <result pre="with COVID-19, histopathology of lung specimens from patients with early" exact="disease" post="shows characteristic findings of ARDS and evidence of small"/>
  <result pre="small vessel occlusion.50,51 There are several mechanisms by which SARS-CoV-2" exact="infection" post="may result in microvascular and macrovascular thrombosis, including cytokine"/>
  <result pre="promotes fibrin generation and limits fibrinolysis,53,54 hypoxic vaso-occlusion, and direct" exact="viral" post="effects with cell activation (Figure 1). It remains an"/>
  <result pre="active area of investigation whether these are specific to SARS-CoV-2" exact="infection" post="or a final common pathway in the thromboinflammatory response"/>
  <result pre="or a final common pathway in the thromboinflammatory response to" exact="viral" post="infections and a marker of disease severity. Early COVID-19"/>
  <result pre="a final common pathway in the thromboinflammatory response to viral" exact="infections" post="and a marker of disease severity. Early COVID-19 autopsy"/>
  <result pre="the thromboinflammatory response to viral infections and a marker of" exact="disease" post="severity. Early COVID-19 autopsy reports have also identified a"/>
  <result pre="platelets.59â€&quot;62 Consistent with these observations, patients with severe COVID-19 have" exact="elevated serum" post="markers of neutrophil activation and NET formation.63 In one"/>
  <result pre="patients with COVID-19.64 Figure 1. Immune activation and mechanisms of" exact="coagulopathy" post="in patients with coronavirus disease 2019 (COVID-19). Multiple processes"/>
  <result pre="Immune activation and mechanisms of coagulopathy in patients with coronavirus" exact="disease" post="2019 (COVID-19). Multiple processes may contribute to COVID-19-associated coagulopathy"/>
  <result pre="mechanisms of coagulopathy in patients with coronavirus disease 2019 (COVID-19)." exact="Multiple" post="processes may contribute to COVID-19-associated coagulopathy including direct infection"/>
  <result pre="coronavirus disease 2019 (COVID-19). Multiple processes may contribute to COVID-19-associated" exact="coagulopathy" post="including direct infection of type II pneumocytes and endothelial"/>
  <result pre="(COVID-19). Multiple processes may contribute to COVID-19-associated coagulopathy including direct" exact="infection" post="of type II pneumocytes and endothelial cells, leading to"/>
  <result pre="processes may contribute to COVID-19-associated coagulopathy including direct infection of" exact="type II" post="pneumocytes and endothelial cells, leading to barrier dysfunction and"/>
  <result pre="extracellular traps; PAI-1, plasminogen activator inhibitor-1; TF, tissue factor; TNF-Î±," exact="tumor" post="necrosis factor-alpha. Dysregulation of hemostasis and coagulopathy in acute"/>
  <result pre="tissue factor; TNF-Î±, tumor necrosis factor-alpha. Dysregulation of hemostasis and" exact="coagulopathy" post="in acute respiratory distress syndrome (ARDS) Thrombi in the"/>
  <result pre="TNF-Î±, tumor necrosis factor-alpha. Dysregulation of hemostasis and coagulopathy in" exact="acute" post="respiratory distress syndrome (ARDS) Thrombi in the pulmonary micro-"/>
  <result pre="tumor necrosis factor-alpha. Dysregulation of hemostasis and coagulopathy in acute" exact="respiratory" post="distress syndrome (ARDS) Thrombi in the pulmonary micro- and"/>
  <result pre="factor-alpha. Dysregulation of hemostasis and coagulopathy in acute respiratory distress" exact="syndrome" post="(ARDS) Thrombi in the pulmonary micro- and macrovasculature are"/>
  <result pre="coagulopathy in acute respiratory distress syndrome (ARDS) Thrombi in the" exact="pulmonary" post="micro- and macrovasculature are observed in patients with ARDS"/>
  <result pre="with or without overt DIC, and changes consistent with a" exact="prothrombotic state" post="have been found both in blood and in alveolar"/>
  <result pre="thrombomodulin and PAI-1 are also associated with multiple organ failure," exact="disease" post="severity, and mortality in ARDS in some studies.53,68â€&quot;72 Finally,"/>
  <result pre="factor are higher in patients with ARDS than patients with" exact="pulmonary" post="edema.73 Mechanistically, there is increased thrombin generation by tissue"/>
  <result pre="D-dimer, a breakdown product of crosslinked fibrin, may result from" exact="residual" post="t-PA/plasmin activity, as well as from alternative fibrinolytic pathways"/>
  <result pre="neutrophil elastase activity.74,75 As patients with COVID-19 frequently have isolated" exact="pulmonary" post="findings, the initial hemostatic dysregulation may be localized to"/>
  <result pre="have isolated pulmonary findings, the initial hemostatic dysregulation may be" exact="localized" post="to the lungs as a consequence of the bidirectional"/>
  <result pre="the SARS epidemic provide possible viral-specific mechanisms for ARDS and" exact="uncontrolled" post="coagulation. Autopsy studies of patients who died of SARS"/>
  <result pre="(NFÎºB)-driven inflammatory module, resulting in production of proinflammatory cytokines including" exact="monocyte" post="chemoattractant protein 1 (MCP-1), transforming growth factor-beta 1 (TGF-Î²1),"/>
  <result pre="monocyte chemoattractant protein 1 (MCP-1), transforming growth factor-beta 1 (TGF-Î²1)," exact="tumor" post="necrosis factor-alpha (TNF-Î±), interleukin (IL)-1Î², and IL-6, which have"/>
  <result pre="result in tissue damage, disruption of the endothelial barrier, and" exact="uncontrolled" post="activation of coagulation.54 Overall, these findings are consistent with"/>
  <result pre="model in which SARS-CoV and SARS-CoV-2 directly infect endothelial and" exact="epithelial" post="cells, increasing levels of proinflammatory cytokines, causing immune-mediated damage"/>
  <result pre="that increased fibrinolysis led to a positive feedback loop of" exact="vascular" post="permeability, leukocyte recruitment, and fibrin generation. Interestingly, one hypothesis"/>
  <result pre="that elevated plasminogen may be a risk factor for SARS-CoV-2" exact="infection" post="because plasmin may cleave the S protein of the"/>
  <result pre="its infectivity.94 These findings highlight the delicate balance between corralling" exact="infection" post="and uncontrolled inflammation and thrombosis. Therapeutic considerations Markers of"/>
  <result pre="These findings highlight the delicate balance between corralling infection and" exact="uncontrolled" post="inflammation and thrombosis. Therapeutic considerations Markers of hypercoagulability and"/>
  <result pre="trials targeting various components of inflammatory and coagulation pathways in" exact="acute" post="lung injury, ARDS or sepsis. Studies with heparin, steroids,"/>
  <result pre="in clinical trials to prevent the hyperinflammatory response or mitigate" exact="uncontrolled" post="coagulation. As elevations in D-dimer and FDPs likely reflect"/>
  <result pre="however, the study did not control for other markers of" exact="disease" post="severity nor other therapies, such as antivirals. The study"/>
  <result pre="with severe infection. Heparin may alter the biology of the" exact="disease" post="not only through its anticoagulant properties, but also due"/>
  <result pre="expert recommendations, including interim guidelines from the International Society on" exact="Thrombosis" post="and Haemostasis (ISTH) and the American College of Cardiology"/>
  <result pre="the International Society on Thrombosis and Haemostasis (ISTH) and the" exact="American" post="College of Cardiology (ACC), recommend use of prophylactic dose"/>
  <result pre="prophylaxis with LMWH or direct oral anticoagulants after hospitalization for" exact="acute" post="medical illness reduces the risk of VTE with an"/>
  <result pre="patients with elevated risk of VTE, such as patients with" exact="cancer" post="or prolonged immobility who have low bleeding risk. Given"/>
  <result pre="as patients with cancer or prolonged immobility who have low" exact="bleeding" post="risk. Given early reports and ongoing concerns of high"/>
  <result pre="benefit of therapeutic anticoagulation remains uncertain, with a risk of" exact="bleeding" post="complications in critically ill patients with respiratory failure.95,107 Clinical"/>
  <result pre="a risk of bleeding complications in critically ill patients with" exact="respiratory" post="failure.95,107 Clinical trials will help define the role of"/>
  <result pre="patients with COVID-19. Although these findings are provocative, interpretation is" exact="limited" post="by their observational nature.108 There are over 300 trials"/>
  <result pre="and T-cell activation, upstream of cytokine effectors.58,110 Dipyridamole induces a" exact="type I" post="interferon response, which is necessary for physiologic anti-viral activity,"/>
  <result pre="and inhibits SARS-CoV-2 replication in vitro by inhibiting a critical" exact="viral" post="replication complex.111,112 Administered orally, dipyridamole has a favorable safety"/>
  <result pre="late physiologic anti-viral responses. The heterogenous response to the SARS-CoV-2" exact="infection" post="and the various time-dependent pathways driving pathology make universal"/>
  <result pre="temporal and mechanistic role each pathway plays in severe SARS-CoV-2" exact="infection" post="remains uncertain and requires further exploration for treatment opportunities"/>
  <result pre="and mortality. Laboratory, clinical, and early histopathologic findings suggest this" exact="coagulopathy" post="is distinct from sepsis-induced DIC and may reflect dysregulated"/>
  <result pre="dysregulated hemostasis. Similar findings have been associated with several other" exact="viral" post="infections, and it remains uncertain if this coagulopathy is"/>
  <result pre="several other viral infections, and it remains uncertain if this" exact="coagulopathy" post="is specific to SARS-CoV-2 or the end common pathway"/>
  <result pre="the end common pathway of the thrombo-inflammatory response to severe" exact="viral" post="infections. There are efforts to target numerous components of"/>
  <result pre="and has a pending patent on use of biogases in" exact="vascular" post="disease. Neither author has related financial conflicts of interest"/>
  <result pre="article: MEC is supported by the National Heart, Lung, and" exact="Blood" post="Institute (NHLBI) of the National Institutes of Health (NIH)."/>
  <result pre="Impact Research Ignitor Program, Falk Medical Research Trust Catalyst Award," exact="American" post="Venous Forum-JOBST Award, University of Michigan BioInterfaces Institute, and"/>
  <result pre="Forum-JOBST Award, University of Michigan BioInterfaces Institute, and Bo Schembechler" exact="Heart" post="of A Champion Foundation. ORCID iD: Yogendra Kanthi https://orcid.org/0000-0002-5660-5194"/>
  <result pre="iD: Yogendra Kanthi https://orcid.org/0000-0002-5660-5194 References References 1collab: World Health Organization." exact="Pneumonia" post="of unknown cause â€&quot; China. Disease outbreak news, 51,"/>
  <result pre="1collab: World Health Organization. Pneumonia of unknown cause â€&quot; China." exact="Disease" post="outbreak news, 51, https://www.who.int/csr/don/05-january-2020-pneumonia-of-unkown-cause-china/en/ (2020, accessed 2532020). 2ZhuNZhangDWangW, et"/>
  <result pre="accessed 2532020). 2ZhuNZhangDWangW, et al.A novel coronavirus from patients with" exact="pneumonia" post="in China, 2019. N Engl J Med2020; 382: 727â€&quot;733.31978945"/>
  <result pre="China. Lancet2020; 395: 497â€&quot;506.31986264 6GuanWJNiZYHuY, et al.Clinical characteristics of coronavirus" exact="disease" post="2019 in China. N Engl J Med2020; 382: 1708â€&quot;1720.32109013"/>
  <result pre="with hospitalization and critical illness among 4,103 patients with COVID-19" exact="disease" post="in New York City. BMJ2020; 369: m1966.32444366 8SaifLJ.Animal coronavirus"/>
  <result pre="(Basel)2004; 119: 129â€&quot;140.15742624 9KuikenTFouchierRASchuttenM, et al.Newly discovered coronavirus as the" exact="primary" post="cause of severe acute respiratory syndrome. Lancet2003; 362: 263â€&quot;270.12892955"/>
  <result pre="et al.Newly discovered coronavirus as the primary cause of severe" exact="acute" post="respiratory syndrome. Lancet2003; 362: 263â€&quot;270.12892955 10DrostenCGuntherSPreiserW, et al.Identification of"/>
  <result pre="al.Newly discovered coronavirus as the primary cause of severe acute" exact="respiratory" post="syndrome. Lancet2003; 362: 263â€&quot;270.12892955 10DrostenCGuntherSPreiserW, et al.Identification of a"/>
  <result pre="et al.Identification of a novel coronavirus in patients with severe" exact="acute" post="respiratory syndrome. N Engl J Med2003; 348: 1967â€&quot;1976.12690091 11KsiazekTGErdmanDGoldsmithCS,"/>
  <result pre="al.Identification of a novel coronavirus in patients with severe acute" exact="respiratory" post="syndrome. N Engl J Med2003; 348: 1967â€&quot;1976.12690091 11KsiazekTGErdmanDGoldsmithCS, et"/>
  <result pre="348: 1967â€&quot;1976.12690091 11KsiazekTGErdmanDGoldsmithCS, et al.A novel coronavirus associated with severe" exact="acute" post="respiratory syndrome. N Engl J Med2003; 348: 1953â€&quot;1966.12690092 12De"/>
  <result pre="1967â€&quot;1976.12690091 11KsiazekTGErdmanDGoldsmithCS, et al.A novel coronavirus associated with severe acute" exact="respiratory" post="syndrome. N Engl J Med2003; 348: 1953â€&quot;1966.12690092 12De GrootRJBakerSCBaricRS,"/>
  <result pre="Engl J Med2003; 348: 1953â€&quot;1966.12690092 12De GrootRJBakerSCBaricRS, et al.Middle East" exact="respiratory" post="syndrome coronavirus (MERS-CoV): Announcement of the Coronavirus Study Group."/>
  <result pre="J Med2003; 348: 1953â€&quot;1966.12690092 12De GrootRJBakerSCBaricRS, et al.Middle East respiratory" exact="syndrome" post="coronavirus (MERS-CoV): Announcement of the Coronavirus Study Group. J"/>
  <result pre="et al.Isolation of a novel coronavirus from a man with" exact="pneumonia" post="in Saudi Arabia. N Engl J Med2012; 367: 1814â€&quot;1820.23075143"/>
  <result pre="accessed 28 March 2020). 15collab: World Health Organization. Middle East" exact="respiratory" post="syndrome coronavirus (MERS-CoV). MERS Monthly Summary, 112019, http://www.who.int/emergencies/mers-cov/en/ (2019,"/>
  <result pre="28 March 2020). 15collab: World Health Organization. Middle East respiratory" exact="syndrome" post="coronavirus (MERS-CoV). MERS Monthly Summary, 112019, http://www.who.int/emergencies/mers-cov/en/ (2019, accessed"/>
  <result pre="al.Clinical course and outcomes of critically ill patients with SARS-CoV-2" exact="pneumonia" post="in Wuhan, China: A single-centered, retrospective, observational study. Lancet"/>
  <result pre="al.Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected" exact="pneumonia" post="in Wuhan, China. JAMA2020; 323: 1061â€&quot;1069. 18PetrosilloNViceconteGErgonulO, et al.COVID-19,"/>
  <result pre="Infect2020; 26:729â€&quot;734.32234451 19WuZMcGooganJM.Characteristics of and important lessons from the coronavirus" exact="disease" post="2019 (COVID-19) outbreak in China: Summary of a report"/>
  <result pre="a report of 72314 cases from the Chinese Center for" exact="Disease" post="Control and Prevention. JAMA2020; 323: 1239â€&quot;1242. 20ZhouPYangXLWangXG, et al.A"/>
  <result pre="Disease Control and Prevention. JAMA2020; 323: 1239â€&quot;1242. 20ZhouPYangXLWangXG, et al.A" exact="pneumonia" post="outbreak associated with a new coronavirus of probable bat"/>
  <result pre="origin. Nature2020; 579: 270â€&quot;273.32015507 21LippiGPlebaniMHenryBM.Thrombocytopenia is associated with severe coronavirus" exact="disease" post="2019 (COVID-19) infections: A meta-analysis. Clin Chim Acta2020; 506:"/>
  <result pre="Chim Acta2020; 506: 145â€&quot;148.32178975 22WuCChenXCaiY, et al.Risk factors associated with" exact="acute" post="respiratory distress syndrome and death in patients with coronavirus"/>
  <result pre="Acta2020; 506: 145â€&quot;148.32178975 22WuCChenXCaiY, et al.Risk factors associated with acute" exact="respiratory" post="distress syndrome and death in patients with coronavirus disease"/>
  <result pre="145â€&quot;148.32178975 22WuCChenXCaiY, et al.Risk factors associated with acute respiratory distress" exact="syndrome" post="and death in patients with coronavirus disease 2019 pneumonia"/>
  <result pre="acute respiratory distress syndrome and death in patients with coronavirus" exact="disease" post="2019 pneumonia in Wuhan, China. JAMA Intern Med. Epub"/>
  <result pre="distress syndrome and death in patients with coronavirus disease 2019" exact="pneumonia" post="in Wuhan, China. JAMA Intern Med. Epub ahead of"/>
  <result pre="and clinical characteristics of 99 cases of 2019 novel coronavirus" exact="pneumonia" post="in Wuhan, China: A descriptive study. Lancet2020; 395: 507â€&quot;513.32007143"/>
  <result pre="25ZhouFYuTDuR, et al.Clinical course and risk factors for mortality of" exact="adult" post="inpatients with COVID-19 in Wuhan, China: A retrospective cohort"/>
  <result pre="Lancet2020; 395: 1054â€&quot;1062.32171076 26IbaTLevyJHWarkentinTE, et al.Diagnosis and management of sepsis-induced" exact="coagulopathy" post="and disseminated intravascular coagulation. J Thromb Haemost2019; 17: 1989â€&quot;1994.31410983"/>
  <result pre="1054â€&quot;1062.32171076 26IbaTLevyJHWarkentinTE, et al.Diagnosis and management of sepsis-induced coagulopathy and" exact="disseminated intravascular coagulation." post="J Thromb Haemost2019; 17: 1989â€&quot;1994.31410983 27IbaTDi NisioMThachilJ, et al.A"/>
  <result pre="et al.A proposal of the modification of Japanese Society on" exact="Thrombosis" post="and Hemostasis (JSTH) Disseminated Intravascular Coagulation (DIC) diagnostic criteria"/>
  <result pre="the modification of Japanese Society on Thrombosis and Hemostasis (JSTH)" exact="Disseminated Intravascular" post="Coagulation (DIC) diagnostic criteria for sepsis-associated DIC. Clin Appl"/>
  <result pre="modification of Japanese Society on Thrombosis and Hemostasis (JSTH) Disseminated" exact="Intravascular Coagulation (DIC)" post="diagnostic criteria for sepsis-associated DIC. Clin Appl Thromb Hemost2018;"/>
  <result pre="of Japanese Society on Thrombosis and Hemostasis (JSTH) Disseminated Intravascular" exact="Coagulation (DIC)" post="diagnostic criteria for sepsis-associated DIC. Clin Appl Thromb Hemost2018;"/>
  <result pre="al.D-dimer is a significant prognostic factor in patients with suspected" exact="infection" post="and sepsis. Am J Emerg Med2012; 30: 1991â€&quot;1999.22795996 31WanJYangXHeW,"/>
  <result pre="al.Serum D-dimer levels at admission for prediction of outcomes in" exact="acute" post="pancreatitis. BMC Gastroenterol2019; 19: 67.31046705 32GoeijenbierMvan WissenMvan de WegC,"/>
  <result pre="BMC Gastroenterol2019; 19: 67.31046705 32GoeijenbierMvan WissenMvan de WegC, et al.Review:" exact="Viral" post="infections and mechanisms of thrombosis and bleeding. J Med"/>
  <result pre="Gastroenterol2019; 19: 67.31046705 32GoeijenbierMvan WissenMvan de WegC, et al.Review: Viral" exact="infections" post="and mechanisms of thrombosis and bleeding. J Med Virol2012;"/>
  <result pre="WissenMvan de WegC, et al.Review: Viral infections and mechanisms of" exact="thrombosis" post="and bleeding. J Med Virol2012; 84: 1680â€&quot;1696.22930518 33WongRSWuAToKF, et"/>
  <result pre="84: 1680â€&quot;1696.22930518 33WongRSWuAToKF, et al.Haematological manifestations in patients with severe" exact="acute" post="respiratory syndrome: Retrospective analysis. BMJ2003; 326: 1358â€&quot;1362.12816821 34SoepandiPZBurhanEMangunnegoroH, et"/>
  <result pre="1680â€&quot;1696.22930518 33WongRSWuAToKF, et al.Haematological manifestations in patients with severe acute" exact="respiratory" post="syndrome: Retrospective analysis. BMJ2003; 326: 1358â€&quot;1362.12816821 34SoepandiPZBurhanEMangunnegoroH, et al.Clinical"/>
  <result pre="Retrospective analysis. BMJ2003; 326: 1358â€&quot;1362.12816821 34SoepandiPZBurhanEMangunnegoroH, et al.Clinical course of" exact="avian influenza" post="A(H5N1) in patients at the Persahabatan Hospital, Jakarta, Indonesia,"/>
  <result pre="novel influenza A(H1N1). Thromb Res2011; 127: 198â€&quot;201.21216444 36collab: Centers for" exact="Disease" post="Control and Prevention. Intensive-care patients with severe novel influenza"/>
  <result pre="and Prevention. Intensive-care patients with severe novel influenza A (H1N1)" exact="virus infection" post="â€&quot; Michigan, June 2009. MMWR Morb Mortal Wkly Rep2009;"/>
  <result pre="Prevention. Intensive-care patients with severe novel influenza A (H1N1) virus" exact="infection" post="â€&quot; Michigan, June 2009. MMWR Morb Mortal Wkly Rep2009;"/>
  <result pre="J Intern Med2015; 26: 596â€&quot;598.26365372 38BuncePEHighSMNadjafiM, et al.Pandemic H1N1 influenza" exact="infection" post="and vascular thrombosis. Clin Infect Dis2011; 52: e14â€&quot;17.21288835 39ObiATTignanelliCJJacobsBN,"/>
  <result pre="Med2015; 26: 596â€&quot;598.26365372 38BuncePEHighSMNadjafiM, et al.Pandemic H1N1 influenza infection and" exact="vascular" post="thrombosis. Clin Infect Dis2011; 52: e14â€&quot;17.21288835 39ObiATTignanelliCJJacobsBN, et al.Empirical"/>
  <result pre="vascular thrombosis. Clin Infect Dis2011; 52: e14â€&quot;17.21288835 39ObiATTignanelliCJJacobsBN, et al.Empirical" exact="systemic" post="anticoagulation is associated with decreased venous thromboembolism in critically"/>
  <result pre="e14â€&quot;17.21288835 39ObiATTignanelliCJJacobsBN, et al.Empirical systemic anticoagulation is associated with decreased" exact="venous thromboembolism" post="in critically ill influenza A H1N1 acute respiratory distress"/>
  <result pre="with decreased venous thromboembolism in critically ill influenza A H1N1" exact="acute" post="respiratory distress syndrome patients. J Vasc Surg Venous Lymphat"/>
  <result pre="decreased venous thromboembolism in critically ill influenza A H1N1 acute" exact="respiratory" post="distress syndrome patients. J Vasc Surg Venous Lymphat Disord2019;"/>
  <result pre="thromboembolism in critically ill influenza A H1N1 acute respiratory distress" exact="syndrome" post="patients. J Vasc Surg Venous Lymphat Disord2019; 7: 317â€&quot;324.30477976"/>
  <result pre="Surg Venous Lymphat Disord2019; 7: 317â€&quot;324.30477976 40CuiSChenSLiX, et al.Prevalence of" exact="venous thromboembolism" post="in patients with severe novel coronavirus pneumonia. J Thromb"/>
  <result pre="in Milan, Italy. Thromb Res2020; 191: 9â€&quot;14.32353746 43OxleyTJMoccoJMajidiS, et al.Large-vessel" exact="stroke" post="as a presenting feature of Covid-19 in the young."/>
  <result pre="et al.Cardiovascular implications of fatal outcomes of patients with coronavirus" exact="disease" post="2019 (COVID-19). JAMA Cardiol. Epub ahead of print 27"/>
  <result pre="al.Insights for increased risk of failed fibrinolytic therapy and stent" exact="thrombosis" post="associated with COVID-19 in ST-segment elevation myocardial infarction patients."/>
  <result pre="therapy and stent thrombosis associated with COVID-19 in ST-segment elevation" exact="myocardial infarction" post="patients. Catheter Cardiovasc Interv. Epub ahead of print 30"/>
  <result pre="ahead of print 30 April 2020. DOI: 10.1002/ccd.28948. 47Corrales-MedinaVFMadjidMMusherDM.Role of" exact="acute" post="infection in triggering acute coronary syndromes. Lancet Infect Dis2010;"/>
  <result pre="of print 30 April 2020. DOI: 10.1002/ccd.28948. 47Corrales-MedinaVFMadjidMMusherDM.Role of acute" exact="infection" post="in triggering acute coronary syndromes. Lancet Infect Dis2010; 10:"/>
  <result pre="April 2020. DOI: 10.1002/ccd.28948. 47Corrales-MedinaVFMadjidMMusherDM.Role of acute infection in triggering" exact="acute" post="coronary syndromes. Lancet Infect Dis2010; 10: 83â€&quot;92.20113977 48MadjidMAboshadyIAwanI, et"/>
  <result pre="syndromes. Lancet Infect Dis2010; 10: 83â€&quot;92.20113977 48MadjidMAboshadyIAwanI, et al.Influenza and" exact="cardiovascular" post="disease: Is there a causal relationship?Tex Heart Inst J2004;"/>
  <result pre="et al.Influenza and cardiovascular disease: Is there a causal relationship?Tex" exact="Heart" post="Inst J2004; 31: 4â€&quot;13.15061620 49KwongJCSchwartzKLCampitelliMA, et al.Acute myocardial infarction"/>
  <result pre="causal relationship?Tex Heart Inst J2004; 31: 4â€&quot;13.15061620 49KwongJCSchwartzKLCampitelliMA, et al.Acute" exact="myocardial infarction" post="after laboratory-confirmed influenza infection. N Engl J Med2018; 378:"/>
  <result pre="50TianSHuWNiuL, et al.Pulmonary pathology of early-phase 2019 novel coronavirus (COVID-19)" exact="pneumonia" post="in two patients with lung cancer. J Thorac Oncol2020;"/>
  <result pre="early-phase 2019 novel coronavirus (COVID-19) pneumonia in two patients with" exact="lung cancer." post="J Thorac Oncol2020; 15: 700â€&quot;704.32114094 51XuZShiLWangY, et al.Pathological findings"/>
  <result pre="15: 700â€&quot;704.32114094 51XuZShiLWangY, et al.Pathological findings of COVID-19 associated with" exact="acute" post="respiratory distress syndrome. Lancet Respir Med2020; 8: 420â€&quot;422.32085846 52SebagSCBastaracheJAWareLB.Therapeutic"/>
  <result pre="700â€&quot;704.32114094 51XuZShiLWangY, et al.Pathological findings of COVID-19 associated with acute" exact="respiratory" post="distress syndrome. Lancet Respir Med2020; 8: 420â€&quot;422.32085846 52SebagSCBastaracheJAWareLB.Therapeutic modulation"/>
  <result pre="Med2020; 8: 420â€&quot;422.32085846 52SebagSCBastaracheJAWareLB.Therapeutic modulation of coagulation and fibrinolysis in" exact="acute" post="lung injury and the acute respiratory distress syndrome. Curr"/>
  <result pre="of coagulation and fibrinolysis in acute lung injury and the" exact="acute" post="respiratory distress syndrome. Curr Pharm Biotechnol2011; 12: 1481â€&quot;1496.21401517 53WareLBFangXMatthayMA.Protein"/>
  <result pre="coagulation and fibrinolysis in acute lung injury and the acute" exact="respiratory" post="distress syndrome. Curr Pharm Biotechnol2011; 12: 1481â€&quot;1496.21401517 53WareLBFangXMatthayMA.Protein C"/>
  <result pre="Pharm Biotechnol2011; 12: 1481â€&quot;1496.21401517 53WareLBFangXMatthayMA.Protein C and thrombomodulin in human" exact="acute" post="lung injury. Am J Physiol Lung Cell Mol Physiol2003;"/>
  <result pre="J Physiol Lung Cell Mol Physiol2003; 285: L514â€&quot;521.12754194 54FrantzeskakiFArmaganidisAOrfanosSE.Immunothrombosis in" exact="acute" post="respiratory distress syndrome: Cross talks between inflammation and coagulation."/>
  <result pre="Physiol Lung Cell Mol Physiol2003; 285: L514â€&quot;521.12754194 54FrantzeskakiFArmaganidisAOrfanosSE.Immunothrombosis in acute" exact="respiratory" post="distress syndrome: Cross talks between inflammation and coagulation. Respiration2017;"/>
  <result pre="Respiration2017; 93: 212â€&quot;225.27997925 55FoxSEAkmatbekovAHarbertJL, et al.Pulmonary and cardiac pathology in" exact="African" post="American patients with COVID-19: An autopsy series from New"/>
  <result pre="93: 212â€&quot;225.27997925 55FoxSEAkmatbekovAHarbertJL, et al.Pulmonary and cardiac pathology in African" exact="American" post="patients with COVID-19: An autopsy series from New Orleans."/>
  <result pre="2872â€&quot;2877.30990798 58AliRAGandhiAAMengH, et al.Adenosine receptor agonism protects against NETosis and" exact="thrombosis" post="in antiphospholipid syndrome. Nat Commun2019; 10: 1916. 59KambasKMitroulisIRitisK.The emerging"/>
  <result pre="et al.Adenosine receptor agonism protects against NETosis and thrombosis in" exact="antiphospholipid syndrome." post="Nat Commun2019; 10: 1916. 59KambasKMitroulisIRitisK.The emerging role of neutrophils"/>
  <result pre="Clin Med2019; 8: 2072. 61NoubouossieDFReevesBNStrahlBD, et al.Neutrophils: Back in the" exact="thrombosis" post="spotlight. Blood2019; 133: 2186â€&quot;2197.30898858 62ThalinCHisadaYLundstromS, et al.Neutrophil extracellular traps:"/>
  <result pre="April 2020. DOI: 10.1172/jci.insight.138999. 64ZuoYZuoMYalavarthiS, et al.Neutrophil extracellular traps and" exact="thrombosis" post="in COVID-19. medRxiv. Preprint 5 May 2020. DOI: 10.1101/2020.04.30.20086736."/>
  <result pre="5 May 2020. DOI: 10.1101/2020.04.30.20086736. 65BoneRCFrancisPBPierceAK.Intravascular coagulation associated with the" exact="adult" post="respiratory distress syndrome. Am J Med1976; 61: 585â€&quot;589.984062 66BlondonnetRConstantinJMSapinV,"/>
  <result pre="May 2020. DOI: 10.1101/2020.04.30.20086736. 65BoneRCFrancisPBPierceAK.Intravascular coagulation associated with the adult" exact="respiratory" post="distress syndrome. Am J Med1976; 61: 585â€&quot;589.984062 66BlondonnetRConstantinJMSapinV, et"/>
  <result pre="61: 585â€&quot;589.984062 66BlondonnetRConstantinJMSapinV, et al.A pathophysiologic approach to biomarkers in" exact="acute" post="respiratory distress syndrome. Dis Markers2016; 2016: 3501373.26980924 67HaynesJBHyersTMGiclasPC, et"/>
  <result pre="585â€&quot;589.984062 66BlondonnetRConstantinJMSapinV, et al.A pathophysiologic approach to biomarkers in acute" exact="respiratory" post="distress syndrome. Dis Markers2016; 2016: 3501373.26980924 67HaynesJBHyersTMGiclasPC, et al.Elevated"/>
  <result pre="2016: 3501373.26980924 67HaynesJBHyersTMGiclasPC, et al.Elevated fibrin(ogen) degradation products in the" exact="adult" post="respiratory distress syndrome. Am Rev Respir Dis1980; 122: 841â€&quot;847.6450559"/>
  <result pre="3501373.26980924 67HaynesJBHyersTMGiclasPC, et al.Elevated fibrin(ogen) degradation products in the adult" exact="respiratory" post="distress syndrome. Am Rev Respir Dis1980; 122: 841â€&quot;847.6450559 68SapruACalfeeCSLiuKD,"/>
  <result pre="al.Plasma soluble thrombomodulin levels are associated with mortality in the" exact="acute" post="respiratory distress syndrome. Int Care Med2015; 41: 470â€&quot;478. 69WareLBMatthayMAParsonsPE,"/>
  <result pre="soluble thrombomodulin levels are associated with mortality in the acute" exact="respiratory" post="distress syndrome. Int Care Med2015; 41: 470â€&quot;478. 69WareLBMatthayMAParsonsPE, et"/>
  <result pre="al.Pathogenetic and prognostic significance of altered coagulation and fibrinolysis in" exact="acute" post="lung injury/acute respiratory distress syndrome. Crit Care Med2007; 35:"/>
  <result pre="significance of altered coagulation and fibrinolysis in acute lung injury/acute" exact="respiratory" post="distress syndrome. Crit Care Med2007; 35: 1821â€&quot;1828.17667242 70ThompsonBTChambersRCLiuKD.Acute respiratory"/>
  <result pre="injury/acute respiratory distress syndrome. Crit Care Med2007; 35: 1821â€&quot;1828.17667242 70ThompsonBTChambersRCLiuKD.Acute" exact="respiratory" post="distress syndrome. N Engl J Med2017; 377: 1904â€&quot;1905. 71PrabhakaranPWareLBWhiteKE,"/>
  <result pre="1904â€&quot;1905. 71PrabhakaranPWareLBWhiteKE, et al.Elevated levels of plasminogen activator inhibitor-1 in" exact="pulmonary" post="edema fluid are associated with mortality in acute lung"/>
  <result pre="inhibitor-1 in pulmonary edema fluid are associated with mortality in" exact="acute" post="lung injury. Am J Physiol Lung Cell Mol Physiol2003;"/>
  <result pre="and predictive value of biomarkers in patients with ALI and" exact="lower" post="severity of illness: Results from two clinical trials. Am"/>
  <result pre="fibrinolysis is not sufficient to overcome the fibrinolytic shutdown of" exact="disseminated intravascular coagulation" post="associated with systemic inflammation. Thromb Res2007; 121: 67â€&quot;73.17397908 76KoupenovaMClancyLCorkreyHA,"/>
  <result pre="overcome the fibrinolytic shutdown of disseminated intravascular coagulation associated with" exact="systemic" post="inflammation. Thromb Res2007; 121: 67â€&quot;73.17397908 76KoupenovaMClancyLCorkreyHA, et al.Circulating platelets"/>
  <result pre="of tissue factor. J Thromb Haemost2009; 7(suppl 1): 136â€&quot;139.19630786 78ChangJC.Acute" exact="respiratory" post="distress syndrome as an organ phenotype of vascular microthrombotic"/>
  <result pre="factor. J Thromb Haemost2009; 7(suppl 1): 136â€&quot;139.19630786 78ChangJC.Acute respiratory distress" exact="syndrome" post="as an organ phenotype of vascular microthrombotic disease: Based"/>
  <result pre="136â€&quot;139.19630786 78ChangJC.Acute respiratory distress syndrome as an organ phenotype of" exact="vascular" post="microthrombotic disease: Based on hemostatic theory and endothelial molecular"/>
  <result pre="81GlasGJVan Der SluijsKFSchultzMJ, et al.Bronchoalveolar hemostasis in lung injury and" exact="acute" post="respiratory distress syndrome. J Thromb Haemost2013; 11: 17â€&quot;25.23114008 82TomashefskiJFJr.Pulmonary"/>
  <result pre="Der SluijsKFSchultzMJ, et al.Bronchoalveolar hemostasis in lung injury and acute" exact="respiratory" post="distress syndrome. J Thromb Haemost2013; 11: 17â€&quot;25.23114008 82TomashefskiJFJr.Pulmonary pathology"/>
  <result pre="distress syndrome. J Thromb Haemost2013; 11: 17â€&quot;25.23114008 82TomashefskiJFJr.Pulmonary pathology of" exact="acute" post="respiratory distress syndrome. Clin Chest Med2000; 21: 435â€&quot;466.11019719 83VesconiSRossiGPPesentiA,"/>
  <result pre="syndrome. J Thromb Haemost2013; 11: 17â€&quot;25.23114008 82TomashefskiJFJr.Pulmonary pathology of acute" exact="respiratory" post="distress syndrome. Clin Chest Med2000; 21: 435â€&quot;466.11019719 83VesconiSRossiGPPesentiA, et"/>
  <result pre="Chest Med2000; 21: 435â€&quot;466.11019719 83VesconiSRossiGPPesentiA, et al.Pulmonary microthrombosis in severe" exact="adult" post="respiratory distress syndrome. Crit Care Med1988; 16: 111â€&quot;113.3342622 84HeYZhouYLiuS,"/>
  <result pre="Med2000; 21: 435â€&quot;466.11019719 83VesconiSRossiGPPesentiA, et al.Pulmonary microthrombosis in severe adult" exact="respiratory" post="distress syndrome. Crit Care Med1988; 16: 111â€&quot;113.3342622 84HeYZhouYLiuS, et"/>
  <result pre="Res Commun2004; 324: 773â€&quot;781.15474494 85LiWGreenoughTCMooreMJ, et al.Efficient replication of severe" exact="acute" post="respiratory syndrome coronavirus in mouse cells is limited by"/>
  <result pre="Commun2004; 324: 773â€&quot;781.15474494 85LiWGreenoughTCMooreMJ, et al.Efficient replication of severe acute" exact="respiratory" post="syndrome coronavirus in mouse cells is limited by murine"/>
  <result pre="324: 773â€&quot;781.15474494 85LiWGreenoughTCMooreMJ, et al.Efficient replication of severe acute respiratory" exact="syndrome" post="coronavirus in mouse cells is limited by murine angiotensin-converting"/>
  <result pre="of severe acute respiratory syndrome coronavirus in mouse cells is" exact="limited" post="by murine angiotensin-converting enzyme 2. J Virol2004; 78: 11429â€&quot;11433.15452268"/>
  <result pre="in SARS-CoV-infected ACE2+ cells in SARS patients: Relation to the" exact="acute" post="lung injury and pathogenesis of SARS. J Pathol2006; 210:"/>
  <result pre="of SARS. J Pathol2006; 210: 288â€&quot;297.17031779 91VargaZFlammerAJSteigerP, et al.Endothelial cell" exact="infection" post="and endotheliitis in COVID-19. Lancet2020; 395: 1417â€&quot;1418.32325026 92GralinskiLEBankheadA3rdJengS, et"/>
  <result pre="in COVID-19. Lancet2020; 395: 1417â€&quot;1418.32325026 92GralinskiLEBankheadA3rdJengS, et al.Mechanisms of severe" exact="acute" post="respiratory syndrome coronavirus-induced acute lung injury. mBio2013; 4: e00271-13.23919993"/>
  <result pre="COVID-19. Lancet2020; 395: 1417â€&quot;1418.32325026 92GralinskiLEBankheadA3rdJengS, et al.Mechanisms of severe acute" exact="respiratory" post="syndrome coronavirus-induced acute lung injury. mBio2013; 4: e00271-13.23919993 93BerriFRimmelzwaanGFHanssM,"/>
  <result pre="Lancet2020; 395: 1417â€&quot;1418.32325026 92GralinskiLEBankheadA3rdJengS, et al.Mechanisms of severe acute respiratory" exact="syndrome" post="coronavirus-induced acute lung injury. mBio2013; 4: e00271-13.23919993 93BerriFRimmelzwaanGFHanssM, et"/>
  <result pre="1417â€&quot;1418.32325026 92GralinskiLEBankheadA3rdJengS, et al.Mechanisms of severe acute respiratory syndrome coronavirus-induced" exact="acute" post="lung injury. mBio2013; 4: e00271-13.23919993 93BerriFRimmelzwaanGFHanssM, et al.Plasminogen controls"/>
  <result pre="93BerriFRimmelzwaanGFHanssM, et al.Plasminogen controls inflammation and pathogenesis of influenza virus" exact="infections" post="via fibrinolysis. PLoS Pathog2013; 9: e1003229.23555246 94JiHLZhaoRMatalonS, et al.Elevated"/>
  <result pre="monoclonal antibody to human tumour necrosis factor in treatment of" exact="septic shock." post="NORASEPT II Study Group. Lancet1998; 351: 929â€&quot;933.9734938 97AbrahamEWunderinkRSilvermanH, et"/>
  <result pre="97AbrahamEWunderinkRSilvermanH, et al.Efficacy and safety of monoclonal antibody to human" exact="tumor" post="necrosis factor alpha in patients with sepsis syndrome. A"/>
  <result pre="Study Group. JAMA1995; 273: 934â€&quot;941.7884952 98collab: National Heart, Lung, and" exact="Blood" post="Institute ARDS Clinical Trials Network, TruwitJDBernardGR, et al.Rosuvastatin for"/>
  <result pre="Institute ARDS Clinical Trials Network, TruwitJDBernardGR, et al.Rosuvastatin for sepsis-associated" exact="acute" post="respiratory distress syndrome. N Engl J Med2014; 370: 2191â€&quot;2200.24835849"/>
  <result pre="ARDS Clinical Trials Network, TruwitJDBernardGR, et al.Rosuvastatin for sepsis-associated acute" exact="respiratory" post="distress syndrome. N Engl J Med2014; 370: 2191â€&quot;2200.24835849 99BernardGRWheelerAPRussellJA,"/>
  <result pre="912â€&quot;918.9070471 100SteinbergKPHudsonLDGoodmanRB, et al.Efficacy and safety of corticosteroids for persistent" exact="acute" post="respiratory distress syndrome. N Engl J Med2006; 354: 1671â€&quot;1684.16625008"/>
  <result pre="100SteinbergKPHudsonLDGoodmanRB, et al.Efficacy and safety of corticosteroids for persistent acute" exact="respiratory" post="distress syndrome. N Engl J Med2006; 354: 1671â€&quot;1684.16625008 101TangNBaiHChenX,"/>
  <result pre="al.Anticoagulant treatment is associated with decreased mortality in severe coronavirus" exact="disease" post="2019 patients with coagulopathy. J Thromb Haemost2020; 18: 1094â€&quot;1099.32220112"/>
  <result pre="102ThachilJTangNGandoS, et al.ISTH interim guidance on recognition and management of" exact="coagulopathy" post="in COVID-19. J Thromb Haemost2020; 18: 1023â€&quot;1026.32338827 103BikdeliBMadhavanMVJimenezD, et"/>
  <result pre="Thromb Haemost2017; 117: 606â€&quot;617.28078350 107CookDJFullerHDGuyattGH, et al.Risk factors for gastrointestinal" exact="bleeding" post="in critically ill patients. Canadian Critical Care Trials Group."/>
  <result pre="randomized, placebo-controlled, pilot clinical trial of dipyridamole to decrease HIV-associated" exact="chronic" post="inflammation. J Infect Dis2020; 221: 1598â€&quot;1606.31282542 111LiZLiXHuangY-Y, et al.FEP-based"/>
 </snippets>
</snippetsTree>
